BioWorld

Aug. 30, 2010

View Archived Issues

Genentech Caught off Guard, FDA Issues Refuse-to-File for T-DM1

The FDA sent a refuse-to-file letter to Genentech Inc., a member of the Roche Group, rejecting the company's application for accelerated approval of trastuzumab-DM1 (T-DM1) and catching investors and the company off guard. (BioWorld Today) Read More

Otonomy Lures New Investors with $38.5M Series B Financing

Read More

Senate to Hold Hearing on Funding for Stem Cells

Read More

FDA Oversteps its Bounds for Jazz Fibromyalgia Drug

Read More

Genzyme's ERT Rationing to End Soon; Sanofi Still Biting?

Read More

Corrections & Clarifications

Read More

Clinic Roundup

Read More

Stock Movers

Read More

Financings Roundup

Read More

Other News To Note

Read More

U.S. Patent Disclosures

Read More

Bench Press

Read More